Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Rush University Medical Center
Montefiore Medical Center
Case Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Danish Breast Cancer Cooperative Group
Karolinska Institutet
Imperial College London
Milton S. Hershey Medical Center
The Christie NHS Foundation Trust
University of Utah
Universidad de Granada
GE Healthcare
M.D. Anderson Cancer Center
EirGenix, Inc.
Centre Oscar Lambret
Medicos e Investigadores en la Lucha contra el Cancer de Mama
City of Hope Medical Center
Institut Bergonié
Institut Bergonié
Institut Bergonié
Stanford University
Artiva Biotherapeutics, Inc.
University of Florida
Azienda USL Reggio Emilia - IRCCS
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Queen Mary University of London
Thomas Jefferson University
Thomas Jefferson University
Context Therapeutics Inc.
Orion Biotechnology Polska Sp. z o.o.
Pfizer
Northwestern University
GC Cell Corporation
University of Calgary
University of Toledo
University of Toledo
Tel Aviv University
Travera Inc
Institut Bergonié
University of Alabama at Birmingham
M.D. Anderson Cancer Center
Herning Hospital
Wake Forest University Health Sciences
RemeGen Co., Ltd.
Chang Gung Memorial Hospital
City of Hope Medical Center